Speakers
Joshua Berlin
Head of Corporate Alliances & Business Development
BioCentury Inc.
Karen Bernstein, Ph.D.
Co-Founder & Chairman
BioCentury Inc.
Vivian Bian
China GM
Roche AG
Kerry Blanchard, M.D., Ph.D.
CEO
Everest Medicines Ltd.
Paul Bonanos
Director of Biopharma Intelligence
BioCentury Inc.
Harm-Jan Borgeld, Ph.D.
Global Head, Asia Partnering
Roche
William Wei Cao, Ph.D.
Founder, Chairman & CEO
Gracell Biotechnologies Inc.
Tony Chen
Partner
Jones Day
Li Chen, Ph.D.
CEO & Executive Director
Hua Medicine Ltd.
Ziyi Chen
Managing Director, China Healthcare Analyst
Goldman Sachs
Yongshun Cheng
Former Senior Judge, Beijing High People’s Court and
IP Division Director, Beijing Intellectual Property Institute
Billy Cho
CFO
Zai Lab Ltd.
Hong Chow
Head of China & International
Merck KGaA
Jeff Cranmer
Executive Editor and Head of Daily Global Intelligence
BioCentury Inc.
Jialing Dai
Managing Editor
PharmaDJ & RNDer
James Deng
SVP & GM of Greater China
Becton Dickinson and Co.
Lieming Ding, Ph.D.
Founder, Chairman & CEO
Betta Pharmaceuticals Co. Ltd.
David Dobkin
Managing Director, LifeSci Capital, and CFO
LifeSci Acquisition Corp. and LifeSci Acquisition II Corp.
Samantha Du, Ph.D.
Founder, Chairman & CEO
Zai Lab Ltd.
Olivier d’Arros
Partner
Mavie Technologies
Niels Emmerich, Ph.D.
VP, Global Head Search & Evaluation
AbbVie Inc.
Andrew Emmett
FDA Liaison & Head of U.S. Regulatory Policy
Pfizer Inc.
Rob Etherington
President and CEO
Clene Inc.
Yun Fan
Deputy Director, Real World Evidence Transformation Department
Bo’ao Lecheng Administration of International Medical Tourism Pilot Zone
Min Fang
Managing Director
Warburg Pincus
Lisa Feng
Chief Business Officer & CFO
Zhaoke Ophthalmology
Simone Fishburn, Ph.D.
VP & Editor in Chief
BioCentury Inc.
David Flores
Co-Founder, President & CEO
BioCentury Inc.
GU Gang
Chairman of Hainan Development Holdings Co., Ltd., Director of Boao Lecheng Administration of International Medical Tourism Pilot Zone;
Group Leader of the Joint Working Group of HNA Group
Huijun Gao
Deputy Director-General
Shanghai Food & Drug Safety Institute
Donald Gao
Co-Founder
BioFront Therapeutics and BioFront Drug Discovery Innovation Accelerator
Stephen Hansen
Director of Biopharma Intelligence
BioCentury Inc.
Jing He, M.D., Ph.D.
SVP & Head, China R&D
AstraZeneca plc
Thomas Herget, Ph.D.
Head, Silicon Valley & China Innovation Hubs
Merck Group
Christian Hogg
Executive Director & CEO
Hutchmed China Ltd.
Yoo Seok Hong
CEO
D&D Pharmatech
Tina Hou
Partner
McKinsey & Company
James Huang
Managing Partner
Panacea Venture
Weijian Huang
Deputy Director, Investment Promotion Bureau
Guangzhou Development District
Kewen JIN, M.D.
Managing Partner
Serica Partners
Yiwen Jin
Assistant to President & Head, Corporate Strategic Investment
KingMed Diagnostics
Henk Joos, Ph.D.
General Manager
Agio Capital & Business Solutions
Wei KANG
Executive Advisor
RDPAC (R&D-Based Pharmaceutical Association Committee)
Hans Kang
Managing Director & CEO, Healthcare Infrastructure
CBC Group
Jamie Jae Eun Kim, Ph.D.
Founder & CEO
1ST Biotherapeutics Inc.
Selina Koch, Ph.D.
Executive Editor, Head of Intelligence & Research
BioCentury Inc.
Franck Le Deu
Senior Partner & Co-Leader of Asia Life Sciences Practice
McKinsey & Company
Derong Leng
President
Micro-Tech (Nanjing) Co. Ltd.
Nisa Leung
Managing Partner
Qiming Venture Partners
Kevin Li, Ph.D.
Co-Founder & Managing Partner
LYZZ Capital
Zili Li, M.D. M.D., MPH
Fellow, Drug Information Association, and former VP & Head of Asia Pacific R&D
Johnson & Johnson
Bin Li, Ph.D.
Founder, CEO & Chief Investment Officer
Lake Bleu Capital
Lei Li
Partner
Sidley Austin LLP
Charles Li
Founder & Chairman, Micro Connect and former CEO,
HKEX (Hong Kong Exchanges and Clearing Market)
Ning Li, M.D., Ph.D.
Executive Director, CEO & GM
Shanghai Junshi Biosciences Co. Ltd.
Jing Li, M.D., Ph.D.
Founder & CEO
VelaVigo
William Liang
Chief Commercial Officer & President, Greater China
Zai Lab Ltd.
Miron Lila
Head of Capital Market and Investor Relations
dMed-Clinipace
James C. Lin, D.Phil.
Partner
Davis Polk
Da Liu
Managing Director
CR-CP Life Science Fund
Xin Liu
Partner
Eight Roads Ventures China
Yuwen Liu
Founding Partner, Bohe Angel Fund and
former CEO, BioBay
Brad Loncar
CEO
Loncar Investments
Tim Lou
Chairman & CEO
OriGynMED
Hongbo Lu, Ph.D.
Managing Partner & Chief Investment Officer (China)
Vivo Capital
Xianping Lu, Ph.D.
Founder & Chairman
Shenzhen Chipscreen Biosciences Co. Ltd.
Lauren Martz
Executive Director of Biopharma Intelligence
BioCentury Inc.
Lonnie Moulder
Managing Member
Tellus BioVentures
David Oxley
President, International
Exopharm Ltd.
John Oyler
Founder, Chairman & CEO
BeiGene Ltd.
Eric Pierce
Executive Director, Corporate Alliances
BioCentury Inc.
Jean-Christophe Pointeau
President, China
Pfizer Inc.
Dianna Qian
Partner
Pivotal Bioventure China
Randall Rader
Principal
The Rader Group, and former Chief Judge, U.S. Court of Appeals for the Federal Circuit
Jinsheng Ren
Founder & Chairman
Simcere Pharmaceutical Group Ltd.
Joe Romanelli
CEO
Ji Xing Pharmaceuticals Ltd.
Nimish Shah
Partner
Venrock
Hong Shen, Ph.D.
SVP & Head, Innovation Center China
Roche
Victor Shi, Ph.D.
former Chairman, BayHelix, and
Managing Partner, Serica Partners
Yi Shi, Ph.D.
Founder & Managing Partner
LAV (Lilly Asia Ventures)
Wayne Shi
SVP & Market Lead China
Organon
Ruilin Song
Executive President
PhIRDA (China Pharmaceutical Innovation and Research Development Association)
Ling Su, Ph.D.
Venture Partner
LAV (Lilly Asia Ventures)
Bo Tan
CEO & Co-Chief Investment Officer
Summit Healthcare Acquisition Corp.
Lingshi Tan, Ph.D.
Chairman & CEO
Caidya
Boxiong Tang, Ph.D.
Executive Director
BeiGene Ltd.
Jody Tian
Partner
McKinsey & Co.
Haijun Tian, Ph.D.
Executive Director, China RWE
Novartis AG
Karen Tkach Tuzman, Ph.D.
Director of Biopharma Intelligence and Head of Discovery and Preclinical Research
BioCentury Inc.
John Tsai, M.D.
Head of Global Drug Development and Chief Medical Officer
Novartis AG
Jin Wang
Senior Partner, Leader of China Healthcare Practice
McKinsey & Co.
Leon Wang
Executive Vice-President, International
AstraZeneca plc
Xuelin (Steve) Wang
Partner
Davis Polk
Dan Wang, M.D.
Head of APAC
Johnson & Johnson Innovation
Jonathan Wang
Chief Business Officer
Zai Lab Ltd.
Jonathan Wang, Ph.D.
Chairman and CEO - Inmagene；
Co-founder, BayHelix
Knightley Wei
VP, Medical Affairs
Organon (Shanghai) Pharmaceutical Technology Co. Ltd.
Kevin Wu, Ph.D.
Partner
McKinsey & Co.
Xiaobin WU, Ph.D.
President & Chief Operating Officer
BeiGene Ltd.
Jane Wu
Chief Investment Officer
Springhill Fund
Michelle Xia, Ph.D.
Co-Founder, Chairman & CEO
Akeso Inc.
Fay Xing, M.D.
Managing Director and Co-Head, Biotech/Pharma
CBC Group
Stella Xu, Ph.D.
Managing Partner
Quan Capital
Evan Xu
CFO
Genetron Holdings Ltd.
Feng Xu, Ph.D.
Chief IP Counsel & Associate VP, China and Asia
AstraZeneca plc
Yao-Chang Xu, Ph.D.
Founder & CEO
Abbisko Therapeutics
Phoebe Yan
Partner
Paul Hastings LLP
Steve Yang, Ph.D.
Co-CEO
WuXi AppTec
Mei Yang, Ph.D.
VP of iHS Global
Happy Life Technology
Jason Yang, M.D., Ph.D.
Chief Medical Officer
CStone Pharmaceuticals Co. Ltd.
Dajun Yang, M.D., Ph.D.
Chairman & CEO
Ascentage Pharma
Ingrid Yin, Ph.D
Co-Founder, Managing Partner & Portfolio Manager
Maytech Global Investments
Jin-San Yoo, Ph.D.
Founder, President & CEO
PharmAbcine Inc.
Debra Yu, M.D.
Partner & COO
Panacea Venture
ChengYun Yue, Ph.D.
SVP, Business Development and Project Management
Shanghai MicroPort Medical (Group) Co. Ltd.
Ingrid Zhang
China President
Novartis Pharmaceuticals
Lianshan Zhang, Ph.D.
President of Global R&D
Jiangsu Hengrui Medicine Co. Ltd.
Tony Zhang, Ph.D.
Former Chairman, BayHelix and
Founder & CEO, Tyligand Bioscience
Fangning Zhang
Partner
McKinsey & Co.
Yi Zhang, Ph.D.
Chairman, CEO & CTO
Peijia Medical Ltd.
Songgen Zhang, Ph.D.
Chairman
Tinavi Medical Technologies Co. Ltd.
Jinzhong Zhang, Ph.D.
Co-Founder, Chairman & CEO
Eluminex Biosciences Ltd.
Dayao Zhao, M.D., Ph.D.
CEO & Director
Affamed Therapeutics Co. Ltd.
Alex Zhavoronkov, Ph.D.
Founder & CEO
Insilico Medicine Inc.
Gaobo ZHOU
Partner & Co-Leader, China Healthcare Practice
McKinsey & Co.
Sarah Zhu
Of Counsel
Paul Hastings LLP